Epidemiology Rheumatoid Arthritis in China %E2%80%93 Rapid urbanization presents favorable market potential

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. GeneNews Limited SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Canada, Malaysia, China

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ViroMed Co., Ltd. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, South Korea, China

Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Chemed Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Philippines, Singapore, Indonesia, Mexico, Japan, China

China Shineway Pharmaceutical Group Limited (Symbol:2877) SWOT Analysis, Strategy, Revenues and Profits

China Shineway Pharmaceutical Group Limited (Symbol:2877) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. China Shineway Pharmaceutical Group Limited SWOT Analysis report provides ...

Industries: Pathology | Countries: China

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sinovac Biotech Ltd. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: China

Sinovac Biotech Co., Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Co., Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sinovac Biotech Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: China

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary China Medical System Holdings Limited (CMS) is a pharmaceutical service provider. The company provides marketing promotion and sale of prescription drugs to all therapeutic departments in hospitals. CMS's product portfolio includes deanxit, ursofalk, exacin, xinhuosu, augentropfen stulln mono ...

Industries: Pathology | Countries: China

Santen S.A.S. - Strategic SWOT Analysis Review

Santen S.A.S. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Santen S.A.S. (Santen) is a pharmaceutical company. The company develops and manufactures ophthalmic products for healthcare market. Its products are used for the treatment of corneal and conjunctival disorders, glaucoma and ocular hypertension, retinal / uveal disorders, ocular infections / ...

Industries: Pathology | Countries: China

Mumps - Pipeline Review, H2 2014

Mumps - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • November 2014
  • 38 pages

Mumps - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Mumps - Pipeline Review, H2 2014', provides an overview of the Mumps's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, ...

Industries: Pathology | Countries: World, China

 Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2014

Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.